No description written yet.

Industry Biotechnology Homepage crinetics.com
Sector Healthcare IR page ir.crinetics.com
Tags
—
Press page —

Metrics

Valuation  
Market cap $ 4.232B
Market cap (USD) —
P/E —
PEG —
P/BV 3.55
P/S —
P/OCF -10.02
P/FCF -9.95
Dividend yield —
Turnover / mcap —
Returns  
ROE -40.2%
ROI -49.9%
ROIC -41.6%
Profit margin -6,046.2%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y —
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score -71.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Revenue 7.696M 1.039M 4.013M 0 0 71K 1.193M 2.428M 2.045M
Net profit -465.317M -298.408M -214.529M -163.918M -107.641M -73.812M -50.422M -27.115M -9.157M
Free cash flow -383.684M -229.814M -170.995M -116.861M -89.024M -62.213M -46.873M -20.518M -9.783M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Share price 46.55 51.13 35.58 18.3 28.41 14.11 25.09 29.99 —
Price performance 12m -0.09 0.44 0.94 -0.36 1.01 -0.44 -0.16 — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — — — — — — — 0.00 592,000
Lease liabilities (USD) — — — 5.57M 4.85M 4.01M 3.08M 51.7M 51.7M 48.5M
Cash and deposits (USD) 12.2M 14.2M 45M 40.3M 93.1M 201M 32.7M 54.9M 265M 102M
Right-of-use assets (USD) — — — 2.51M 2.23M 1.89M 1.49M 46.5M 43.5M 40.5M
Cash flow detail
Operating cash flow (USD) -5.47M -9.48M -19.5M -46.4M -62M -88.6M -115M -166M -226M -378M
Purchases of property, plant and equipment (USD) -190,000 -304,000 -1.06M -492,000 -186,000 -436,000 -1.66M -4.69M -3.84M -5.76M
Change in receivables (cash effect) (USD) — — — — — — — 0.00 0.00 -592,000
Change in inventories (cash effect) (USD) — — — — — — — 0.00 0.00 -2.02M
Change in payables (cash effect) (USD) 300,000 47,000 7.36M 696,000 2.72M 6.29M 11M 14.6M 17.5M 29M
Interest paid (cash effect) (USD) -11,000 -8,000 — — — — — — — —
Income taxes paid (cash effect) (USD) — — — — — — — 0.00 0.00 -89,000
Share-based compensation (USD) 270,000 271,000 2.32M 6.29M 10.4M 17.4M 28.3M 40.9M 69.4M 91M
Operating cash flow before change in receivables (USD) — — — — — — — -169M -230M -377M
Free cash flow (OCF - PPE - intangibles) (USD) -5.66M -9.78M -20.5M -46.9M -62.2M -89M -117M -171M -230M -384M
Income detail
Research and development expense (USD) 5.1M 9.23M 24.5M 41.5M 57M 84.3M 130M 169M 240M 332M
↳ 5y CAGR +75.2% +69.8% +47.1% +42.1% +42.3%
Total comprehensive income (USD) -6.02M -9.16M -27.1M -50.3M -73.9M -108M -167M -210M -298M -464M
Comprehensive income to owners (USD) -6.02M -9.16M -27.1M -50.3M -73.9M -108M -167M -210M -298M -464M
Reported Mar 13, 2019 Mar 13, 2019 Mar 13, 2019 Mar 9, 2020 Mar 30, 2021 Mar 30, 2022 Feb 28, 2023 Feb 26, 2026 Feb 26, 2026 Feb 26, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Crinetics Pharmaceuticals, Inc. (ticker CRNX), listed in United States.

ETFs Holding Crinetics Pharmaceuticals, Inc.

ETF Weight in ETF Shares Market value As of
EVNT 2.01% 3,100 $ 263.345K Aug 31, 2026
ESSC 0.62% 2,660 $ 222.163K Jul 31, 2026
TMED 0.26% 1,596 $ 59.722K Jun 30, 2026
TMSL 0.21% 154,770 $ 5.791M Jun 30, 2026
MSSM 0.03% 2,668 $ 226.647K Aug 31, 2026
FESM 0.02% 38,194 $ 1.429M Jun 30, 2026